Conley BA - Search Results

1

Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics.

Conley BA, O'Hara S, Wu S, Melink TJ, Parnes H, Pardoe E, Egorin MJ, Van Echo DA. Conley BA, et al. Cancer Chemother Pharmacol. 1995;37(1-2):139-49. doi: 10.1007/BF00685641. Cancer Chemother Pharmacol. 1995. PMID: 7497583 Clinical Trial.

2

Approaches to optimal dosing of hexamethylene bisacetamide.

Conley BA, Egorin MJ, Sinibaldi V, Sewack G, Kloc C, Roberts L, Zuhowski EG, Forrest A, Van Echo DA. Conley BA, et al. Cancer Chemother Pharmacol. 1992;31(1):37-45. doi: 10.1007/BF00695992. Cancer Chemother Pharmacol. 1992. PMID: 1333894

3

The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide.

Conley BA, Sewack GF, Egorin MJ, Subramanyam B, Page JG, Grieshaber CK. Conley BA, et al. Cancer Chemother Pharmacol. 1991;28(1):33-8. doi: 10.1007/BF00684953. Cancer Chemother Pharmacol. 1991. PMID: 2040031

4

Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function.

Conley BA, Egorin MJ, Sinibaldi V, Van Echo DA. Conley BA, et al. Invest New Drugs. 1990 Nov;8(4):365-7. doi: 10.1007/BF00198592. Invest New Drugs. 1990. PMID: 2150671 Clinical Trial. No abstract available.

5

Pharmacodynamics in cancer therapy.

Ratain MJ, Schilsky RL, Conley BA, Egorin MJ. Ratain MJ, et al. Among authors: conley ba. J Clin Oncol. 1990 Oct;8(10):1739-53. doi: 10.1200/JCO.1990.8.10.1739. J Clin Oncol. 1990. PMID: 2213109 Review.

6

An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.

Subramanyam B, Callery PS, Egorin MJ, Snyder SW, Conley BA. Subramanyam B, et al. Among authors: conley ba. Drug Metab Dispos. 1989 Jul-Aug;17(4):398-401. Drug Metab Dispos. 1989. PMID: 2571479

7

Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580).

Conley BA, Forrest A, Egorin MJ, Zuhowski EG, Sinibaldi V, Van Echo DA. Conley BA, et al. Cancer Res. 1989 Jun 15;49(12):3436-40. Cancer Res. 1989. PMID: 2720696

8

Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction.

Egorin MJ, Conley BA, Forrest A, Zuhowski EG, Sinibaldi V, Van Echo DA. Egorin MJ, et al. Among authors: conley ba. Cancer Res. 1987 Nov 15;47(22):6104-10. Cancer Res. 1987. PMID: 2959359

9

Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.

Conley BA, Hornedo J, Abrams J, Eisenberger M, Hiponia D, Aisner J, Van Echo DA. Conley BA, et al. Cancer Treat Rep. 1987 Sep;71(9):861-2. Cancer Treat Rep. 1987. PMID: 3040246 No abstract available.

10

Involvement of monoamine oxidase and diamine oxidase in the metabolism of the cell differentiating agent hexamethylene bisacetamide (HMBA).

Conley BA, Callery PS, Egorin MJ, Subramanyam B, Geelhaar LA, Pan SS. Conley BA, et al. Life Sci. 1988;43(9):793-800. doi: 10.1016/0024-3205(88)90180-4. Life Sci. 1988. PMID: 3137409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters